Phenylephrine Hydrochloride Injection
Product Images NDC 72205-264

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Phenylephrine Hydrochloride (NDC 72205-264). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Phenyl-inj-100mg-cntr-lable (Phenyl Inj 100mg Cntr Lable)

Phenyl-inj-100mg-cntr-lable (Phenyl Inj 100mg Cntr Lable)
This text provides information about a pharmaceutical product indicated for intravenous use. The product contains various ingredients such as Phenylephrine Dihydrate, Citric Acid Monohydrate, Sodium Chloride, and Sodium Citrate. It also gives directions for storage, pH adjustment, and instructions for dilution. The product is a 100 mg/10 mL vial manufactured by Laboratories Private Limited in Telangana, India. It must be stored between 20°C to 25°C and protected from light. For complete usage instructions, the package insert should be consulted.*
FDA Label Image

Phenyl-inj-100mg-crtn-lable (Phenyl Inj 100mg Crtn Lable)

Phenyl-inj-100mg-crtn-lable (Phenyl Inj 100mg Crtn Lable)
Description: The text is detailing information about Phenylephrine Hydrochloride Injection in a Pharmacy Bulk Package. Each 10 mL vial contains 100 mg of Phenylephrine Hydrochloride at a concentration of 10 mg/mL. The injection is for intravenous use and must be diluted before administration. It should be protected from light and stored in the carton. The product is manufactured by MSN Laboratories in India and distributed by Novadoz Pharmaceuticals in the USA. Instructions for use are provided, and the package insert should be consulted. The pH of the solution ranges from 3.0 to 6.5. This medication should be dispensed within 4 hours once the vial is opened. The contact information for Novadoz Pharmaceuticals is also included.*
FDA Label Image

Phenyl-inj-10mg-cntr-lable (Phenyl Inj 10mg Cntr Lable)

FDA Label Image

Phenyl-inj-10mg-crtn-lable (Phenyl Inj 10mg Crtn Lable)

Phenyl-inj-10mg-crtn-lable (Phenyl Inj 10mg Crtn Lable)
This is a description of a medication called Phenylephrine Hydrochloride Injection, USP, intended for intravenous use. It contains 10 mg Phenylephrine Hydrochloride, 3.5 mg Sodium Chloride, 4 mg Sodium Gifals Dirydrae, 1 mg Citric Acid Monohydrate, and 2 mg Sodium Metabisulfite per mL with water for injection. The solution is pH adjusted with Sodium Hydroxide and Hydrochloric Acid to maintain a pH of 3.0 to 3.65. The usual dosage instructions are provided in the package insert. The product should be kept protected from light, stored between 20°C to 25°C (68°F to 77°F), and discarded if unused. Manufactured by MSN Laboratories Private Limited in India and distributed by Nowadoz Pharmaceuticals LLC in Piscataway, NJ.*
FDA Label Image

Phenyl-inj-50mg-cntr-lable (Phenyl Inj 50mg Cntr Lable)

Phenyl-inj-50mg-cntr-lable (Phenyl Inj 50mg Cntr Lable)
This text contains information about a medication containing Phenylephrine Hydrochloride and other components, which is distributed by NovaLoz Pharmaceuticals LLC. The medication is in injection form with specific instructions for storage and use. It should be stored at a temperature between 20°C to 25°C and is not for direct infusion. The medication must be diluted before intravenous use within 4 hours after the vial is penetrated. Further directions for use can be found in the package insert provided by the manufacturer, MSN Laboratories Private Limited.*
FDA Label Image

Phenyl-inj-50mg-crtn-lable (Phenyl Inj 50mg Crtn Lable)

Phenyl-inj-50mg-crtn-lable (Phenyl Inj 50mg Crtn Lable)
This text provides detailed information about Phenylephrine Hydrochloride Injection in Vials. It specifies the concentration, dosage, proper storage conditions, and instructions for use. The product is intended for intravenous use and must be diluted before administration. It is emphasized to protect the solution from light and complete dispensing within 4 hours of penetration of the pharmacy bulk vial. The manufacturer is MSN Laboratories Private Limited in India, and the product is distributed by Novadoz Pharmaceuticals LLC in the USA.*
FDA Label Image

Phenyl-inj-structure (Phenyl Inj Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.